95 related articles for article (PubMed ID: 18454129)
1. Marked for death.
Petrie K; Zelent A
Nat Cell Biol; 2008 May; 10(5):507-9. PubMed ID: 18454129
[No Abstract] [Full Text] [Related]
2. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
3. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
[TBL] [Abstract][Full Text] [Related]
4. Medicine. Poisonous contacts.
Kogan SC
Science; 2010 Apr; 328(5975):184-5. PubMed ID: 20378808
[No Abstract] [Full Text] [Related]
5. [Advances in the study of etiology and differentiation induction mechanism of acute promyelocytic leukemia].
Liu T; Mao M; Chen Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):666-8. PubMed ID: 11721369
[No Abstract] [Full Text] [Related]
6. A new PML-RARs fusion transcript hints at the important role of PML dysregulation in the pathogenesis of APL.
Opalinska J; Zhou L; Verma A
Leuk Lymphoma; 2007 Mar; 48(3):443-4. PubMed ID: 17454578
[No Abstract] [Full Text] [Related]
7. [Molecular basis of arsenic action in promyelocytic leukemia cells].
Wysocki R; Wiśniewska E
Postepy Biochem; 2002; 48(2):121-30. PubMed ID: 12362602
[No Abstract] [Full Text] [Related]
8. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
9. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
11. The PML nuclear compartment and cancer.
Doucas V; Evans RM
Biochim Biophys Acta; 1996 Dec; 1288(3):M25-9. PubMed ID: 9011178
[No Abstract] [Full Text] [Related]
12. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
[TBL] [Abstract][Full Text] [Related]
13. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarrays for hypothesis generation.
Dmitrovsky E
J Natl Cancer Inst; 2004 Feb; 96(4):248-9. PubMed ID: 14970265
[No Abstract] [Full Text] [Related]
15. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
16. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
17. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
[TBL] [Abstract][Full Text] [Related]
18. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
[TBL] [Abstract][Full Text] [Related]
19. SUMO: of branched proteins and nuclear bodies.
Seeler JS; Dejean A
Oncogene; 2001 Oct; 20(49):7243-9. PubMed ID: 11704852
[TBL] [Abstract][Full Text] [Related]
20. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
